| Literature DB >> 21165394 |
L N Maslov1, E I Barzakh, A V Krylatov, G A Chernysheva, T Krieg, N V Solenkova, A Yu Lishmanov, S Yu Cybulnikov, Y Zhang.
Abstract
The cardioprotective properties of a δ₂-opioid receptor agonist deltorphin II were studied in rats with coronary occlusion and reperfusion. Opioid receptor ligands and inhibitors (glybenclamide, chelerythrine, and 5-hydroxydecanoate) were injected intravenously before ischemia and reperfusion. A δ₂-opioid receptor agonist deltorphin II significantly decreased the infarction zone/risk zone index. This effect was abolished by naltrexone, naloxone methiodide, and δ₂-opioid receptor antagonist naltriben, but not by a δ₁-opioid receptor antagonist BNTX. The infarct-limiting effect of deltorphin II was not observed after inhibition of protein kinase C or blockade of mitochondrial K(ATP) channels.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21165394 DOI: 10.1007/s10517-010-1000-6
Source DB: PubMed Journal: Bull Exp Biol Med ISSN: 0007-4888 Impact factor: 0.804